You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Patent: 8,007,794


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,007,794
Title:Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
Inventor(s): Zeller; Joerg (Ann Arbor, MI), Poulsen; Kristian T. (San Francisco, CA), Abdiche; Yasmina Noubia (Mountain View, CA), Pons; Jaume (San Bruno, CA), Collier; Sierra Leigh Jones (Menlo Park, CA), Rosenthal; Arnon (Woodside, CA)
Assignee: Rinat Neuroscience Corporation (South San Francisco, CA)
Application Number:12/093,638
Patent Claims:see list of patent claims

Details for Patent 8,007,794

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Teva Branded Pharmaceutical Products R&d, Inc. AJOVY fremanezumab-vfrm Injection 761089 09/14/2018 ⤷  Try a Trial 2025-11-14
Teva Branded Pharmaceutical Products R&d, Inc. AJOVY fremanezumab-vfrm Injection 761089 01/27/2020 ⤷  Try a Trial 2025-11-14
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.